Top Markets
Coin of the day
Soiken Holdings Inc. Soiken Holdings Inc.

Soiken Holdings Inc.

2385
Classificação em ações #26793
Founded in 1994 and headquartered in Toyonaka, Japan, Soiken Holdings Inc.... Founded in 1994 and headquartered in Toyonaka, Japan, Soiken Holdings Inc. primarily focuses on the advancement of biomarkers. The company’s operations span a diverse range of health and wellness sectors. It is actively involved in the creation and commercialization of cosmetics and nutritional supplements, alongside the licensing and continued development of biomarker technologies. Soiken also conducts market research and post-market surveillance specifically for dietary supplements. A key area of its work includes the research, development, and sale of functional materials like lactoferrin, as well as pharmaceuticals derived from ascochlorin. Furthermore, Soiken applies its biomarker expertise to perform clinical evaluations for food products. The company extends its services to provide vital support for physician-initiated pharmaceutical clinical research, comprehensive health screenings, and personalized health guidance. It also partners with health insurance societies to offer contracted health guidance, facilitate specialized health check-ups for dependents of the insured, and implement programs designed for diabetes prevention.
Preço da ação
$1.44
Valor de mercado
$37.72M
Variação (1 dia)
1.38%
Variação (1 ano)
20.03%
País
JP
Negociar Soiken Holdings Inc. (2385)

Categoria

EPS de Soiken Holdings Inc. (2385)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Soiken Holdings Inc., o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Soiken Holdings Inc. de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
$17.32 -
US
$27.74 -
NL
$2.98 -
AU
$-7.98 -
US
- -
CH